Zydus Cadila gets nod from Mexican authority for clinical trials of COVID-19 therapy

In a regulatory filing, Zydus Cadila said it had received approval from the Mexican regulatory authority Cofepris to conduct clinical trials with its biological therapy, Pegylated Interferon alpha-2b, 'PegiHepTM'.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3eCxNtl
via IFTTT